KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Red Violet (RDVT) Gains from Investment Securities (2018 - 2025)

Historic Gains from Investment Securities for Red Violet (RDVT) over the last 8 years, with Q2 2025 value amounting to $1.2 million.

  • Red Violet's Gains from Investment Securities changed N/A to $1.2 million in Q2 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year change of. This contributed to the annual value of $607000.0 for FY2024, which is 6836.89% down from last year.
  • According to the latest figures from Q2 2025, Red Violet's Gains from Investment Securities is $1.2 million.
  • Red Violet's Gains from Investment Securities' 5-year high stood at $1.9 million during Q3 2023, with a 5-year trough of $1000.0 in Q1 2023.
  • Over the past 5 years, Red Violet's median Gains from Investment Securities value was $166666.0 (recorded in 2021), while the average stood at $533952.3.
  • Within the past 5 years, the most significant YoY rise in Red Violet's Gains from Investment Securities was 141514.55% (2021), while the steepest drop was 141514.55% (2021).
  • Quarter analysis of 5 years shows Red Violet's Gains from Investment Securities stood at $166666.0 in 2021, then tumbled by 98.8% to $2000.0 in 2022, then skyrocketed by 95850.0% to $1.9 million in 2023, then plummeted by 95.67% to $83000.0 in 2024, then soared by 1289.16% to $1.2 million in 2025.
  • Its Gains from Investment Securities was $1.2 million in Q2 2025, compared to $83000.0 in Q4 2024 and $1.9 million in Q3 2023.